Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics.

Perkins KA, Lerman C.

Clin Pharmacol Ther. 2011 Mar;89(3):460-3. doi: 10.1038/clpt.2010.254. Epub 2011 Jan 26. No abstract available.

2.

Editorial: clinical use of biomarkers in drug metabolism and adverse drug reactions.

Agundez JA.

Curr Drug Metab. 2014 Feb;15(2):127-8. No abstract available.

PMID:
24655066
3.

The future of biomarkers.

Aruoma OI, Bahorun T.

Toxicology. 2010 Dec 5;278(2):161-4. doi: 10.1016/j.tox.2010.09.015. Epub 2010 Oct 1. No abstract available.

PMID:
20888386
4.

Pharmacogenetics of drugs withdrawn from the market.

Zhang W, Roederer MW, Chen WQ, Fan L, Zhou HH.

Pharmacogenomics. 2012 Jan;13(2):223-31. doi: 10.2217/pgs.11.137.

PMID:
22256871
5.

Pharmacogenetic Markers of Drug Efficacy and Toxicity.

Yip VL, Hawcutt DB, Pirmohamed M.

Clin Pharmacol Ther. 2015 Jul;98(1):61-70. doi: 10.1002/cpt.135. Epub 2015 Jun 3. Review.

PMID:
25870137
6.

Pharmacogenetics and stroke.

Meschia JF.

Stroke. 2009 Nov;40(11):3641-5. doi: 10.1161/STROKEAHA.109.562231. Epub 2009 Sep 17. Review.

7.

Symbiotic relationship of pharmacogenetics and drugs of abuse.

Rutter JL.

AAPS J. 2006 Mar 24;8(1):E174-84. Review.

8.

Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment.

Khokhar JY, Ferguson CS, Zhu AZ, Tyndale RF.

Annu Rev Pharmacol Toxicol. 2010;50:39-61. doi: 10.1146/annurev.pharmtox.010909.105826. Review.

PMID:
20055697
9.

[Pharmacogenetics and the treatment of addiction].

Schellekens A.

Ned Tijdschr Geneeskd. 2013;157(23):A5725. Review. Dutch.

PMID:
23739600
10.

Pharmacogenetics of addiction therapy.

Nielsen DA, Nielsen EM, Dasari T, Spellicy CJ.

Methods Mol Biol. 2014;1175:589-624. doi: 10.1007/978-1-4939-0956-8_15. Review.

PMID:
25150877
11.

Human microdosing; a boon or a bane?

Seth SD, Kumar NK, Dua P.

Indian J Med Res. 2009 Aug;130(2):202-4. No abstract available.

PMID:
19797820
12.

The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.

Roses AD.

Neuropsychopharmacology. 2009 Jan;34(1):6-17. doi: 10.1038/npp.2008.153. Epub 2008 Oct 15. Review.

13.

Breaking barriers in the genomics and pharmacogenetics of drug addiction.

Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, Munafò MR, Tyndale RF.

Clin Pharmacol Ther. 2010 Dec;88(6):779-91. doi: 10.1038/clpt.2010.175. Epub 2010 Oct 27. Review.

14.

Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.

Lazaridis KN.

Clin Pharmacol Ther. 2017 Jan;101(1):39-41. doi: 10.1002/cpt.543. Epub 2016 Nov 21.

PMID:
27804107
15.

Promise of new translational safety biomarkers in drug development and challenges to regulatory qualification.

Sistare FD, DeGeorge JJ.

Biomark Med. 2011 Aug;5(4):497-514. doi: 10.2217/bmm.11.52. Review.

PMID:
21861671
16.

Clinically relevant genetic variations in drug metabolizing enzymes.

Pinto N, Dolan ME.

Curr Drug Metab. 2011 Jun;12(5):487-97. Review.

17.

The determination and interpretation of the therapeutic index in drug development.

Muller PY, Milton MN.

Nat Rev Drug Discov. 2012 Oct;11(10):751-61. doi: 10.1038/nrd3801. Epub 2012 Aug 31. Review.

PMID:
22935759
18.

A generic operational strategy to qualify translational safety biomarkers.

Matheis K, Laurie D, Andriamandroso C, Arber N, Badimon L, Benain X, Bendjama K, Clavier I, Colman P, Firat H, Goepfert J, Hall S, Joos T, Kraus S, Kretschmer A, Merz M, Padro T, Planatscher H, Rossi A, Schneiderhan-Marra N, Schuppe-Koistinen I, Thomann P, Vidal JM, Molac B.

Drug Discov Today. 2011 Jul;16(13-14):600-8. doi: 10.1016/j.drudis.2011.04.011. Epub 2011 May 6. Review.

PMID:
21570476
19.

Obstetric therapeutics-how pharmacogenetics may inform drug therapy for pregnant women in the future.

Haas DM.

Obstet Gynecol Surv. 2013 Sep;68(9):650-4. doi: 10.1097/OGX.0b013e3182a66180. Review.

PMID:
25102121
20.

The pharmacogenetics research network: from SNP discovery to clinical drug response.

Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I; Pharmacogenetics Research Network.

Clin Pharmacol Ther. 2007 Mar;81(3):328-45. Review.

Supplemental Content

Support Center